572 related articles for article (PubMed ID: 31387239)
21. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
22. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
Yang Y; Qu A; Wu Q; Zhang X; Wang L; Li C; Dong Z; Du L; Wang C
Aging (Albany NY); 2020 Jan; 12(1):35-52. PubMed ID: 31926112
[TBL] [Abstract][Full Text] [Related]
24. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
25. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
[TBL] [Abstract][Full Text] [Related]
26. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
27. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
28. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
29. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
30. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
31. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
32. Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer.
Oh SC; Park YY; Park ES; Lim JY; Kim SM; Kim SB; Kim J; Kim SC; Chu IS; Smith JJ; Beauchamp RD; Yeatman TJ; Kopetz S; Lee JS
Gut; 2012 Sep; 61(9):1291-8. PubMed ID: 21997556
[TBL] [Abstract][Full Text] [Related]
33. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
Zhao J; Xu J; Shang AQ; Zhang R
Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G
Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348
[TBL] [Abstract][Full Text] [Related]
35. The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer.
Gong S; Ye W; Liu T; Jian S; Liu W
Biomed Res Int; 2020; 2020():3497810. PubMed ID: 33294438
[TBL] [Abstract][Full Text] [Related]
36. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
[TBL] [Abstract][Full Text] [Related]
37. Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.
Deloria AJ; Höflmayer D; Kienzl P; Łopatecka J; Sampl S; Klimpfinger M; Braunschmid T; Bastian F; Lu L; Marian B; Stättner S; Holzmann K
Oncotarget; 2016 Nov; 7(45):73800-73816. PubMed ID: 27650542
[TBL] [Abstract][Full Text] [Related]
38. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of Gene Expression Profiles Identifies a
Chen Z; Chen M; Xue Z; Zhu X
Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
[No Abstract] [Full Text] [Related]
40. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients.
Sveen A; Ågesen TH; Nesbakken A; Meling GI; Rognum TO; Liestøl K; Skotheim RI; Lothe RA
Clin Cancer Res; 2012 Nov; 18(21):6001-10. PubMed ID: 22991413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
